Krilogy Financial’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Sell
2,435
-333
-12% -$136K 0.03% 375
2026
Q2
$1.08M Sell
2,768
-198
-7% -$83.7K 0.03% 377
2026
Q1
$1.43M Buy
2,966
+1,539
+108% +$775K 0.05% 275
2025
Q4
$674K Sell
1,427
-454
-24% -$211K 0.02% 453
2025
Q3
$890K Buy
+1,881
New +$729K 0.03% 357
2018
Q4
– Sell
-25
Closed -$3K – 352
2018
Q3
$3K Buy
+25
New +$3.11K ﹤0.01% 677
2018
Q2
– Sell
-46
Closed -$4K – 353
2018
Q1
$4K Hold
46
– – ﹤0.01% 625
2017
Q4
$4K Hold
46
– – ﹤0.01% 629
2017
Q3
$4K Buy
46
+21
+84% +$1.69K ﹤0.01% 679
2017
Q2
$2K Sell
25
-75
-75% -$6.34K ﹤0.01% 663
2017
Q1
$7K Hold
100
– – ﹤0.01% 549
2016
Q4
$7K Hold
100
– – ﹤0.01% 549
2016
Q3
$8K Hold
100
– – ﹤0.01% 548
2016
Q2
$8K Hold
100
– – ﹤0.01% 556
2016
Q1
$8K Hold
100
– – ﹤0.01% 484
2015
Q4
$7K Hold
100
– – 0.01% 289
2015
Q3
$8K Buy
+100
New +$8.86K ﹤0.01% 413

Other funds holding HCA

Krilogy Financial's HCA Position: Q3 2026 in Review

Krilogy Financial reduced its HCA Healthcare (HCA) stake by 12% in Q3 2026, selling an estimated $136K and leaving 2,435 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #375.

Krilogy Financial first reported a position in HCA in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.43M in Q1 2026. 1,138 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Krilogy Financial held 2,435 shares of HCA Healthcare worth $1.12M as of Q3 2026.
  • Krilogy Financial sold 333 HCA Healthcare shares in Q3 2026, an estimated $136K.
  • HCA Healthcare made up 0.03% of Krilogy Financial's portfolio in Q3 2026, its #375 holding.
  • Krilogy Financial first reported a position in HCA Healthcare in Q3 2015 and has held it in 17 quarters since.
  • Krilogy Financial's HCA Healthcare position peaked at $1.43M in Q1 2026.
  • 1,138 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.